Please login to create your UC TechAlerts.
Request a new password for
Required
Find technologies available for licensing from UC Davis.
No technologies match these criteria. Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above
A Combined Raman/Single-Molecul Junction System For Chemical/Biological Analysis
Researchers at the University of California, Davis (“UC Davis”) have developed a device for multi-dimensional data extraction at the molecular level.
Robotic Integrated Raman Scanning Optical Head
Researchers at the University of California, Davis have developed an invention that utilizes an integrated Raman scanning head and machine vision for high throughput chemical analysis of liquid biopsy samples.
Non-invasive Sleep Quality Measuring Device
Researchers at the University of California, Davis have developed a sleep quality measuring device to measure waking electroencephalogram (EEG) test to determine the adequacy of sleep
O-Acetyl Glycosphingosines and Gangliosides, as well as Their N-Acetyl Analogs
Researchers at the University of California, Davis have developed a technology providing the creation of stable analogs of glycosphingosines and gangliosides containing O-acetylated sialic acid for extensive biological and medical applications.
Affinity Peptides for Diagnosis and Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 and Zika Virus Infections
Researchers at the University of California, Davis have developed a technology to expedite COVID-19 diagnosis and treatment using viral spike protein (S-protein) targeted peptides Zika virus envelop protein.
Synthesizing Speech From Neural Activity
Researchers at the University of California, Davis have developed a computer-based method to synthesize continuous speech from biosignals, including brain activity, in real-time.
Using Automatic Speech Recognition To Measure The Intelligibility Of Speech Synthesized From Brain Signals
Researchers at the University of California, Davis have developed a computer-based method to evaluate/quantify the intelligibility of speech synthesized by a brain-computer interface or other speech prosthesis.
Bispecific and Trispecific T-cell Engager Antibodies
Researchers at the University of California, Davis have developed multi-specific antibody molecules including bi-specific and tri-specific antibodies that could serve to co-localize effector T-cells, target tumor B-cells and would simultaneously enhance anti-tumor activity and proliferation, whilst minimizing potential systemic toxicities
Artificial Intelligence-Based Evaluation Of Drug Efficacy
Researchers at the University of California, Davis have developed a method of using artificial intelligence for assessing the effectiveness or efficacy of drugs that is cheaper, faster, and more accurate than commonly used assay analyses.
Purification of Glycosphingosines and Glycosphingolipids
Researchers at the University of California, Davis (UC Davis) have developed a simplified procedure to synthesize complex glycosphingosine compounds for the chemical preparation of glycosphingolipids.
Cellular Protein CDH4 Inhibiting Peptide
Researchers at the University of California, Davis have developed a unique peptide that induces cell differentiation by inhibiting cellular protein CHD4, a promising approach to target dedifferentiated cancer cells and for cell therapy.
CHD4 Targeting Peptide Isolated From Viral Protein For Cancer Therapeutics
Researchers at the University of California, Davis have identified a short peptide which rapidly promotes protein degradation in cancerous enzymes and induces cell differentiation to kill lymphomas.
Use Of Viral Il-6 To Modulate Monocyte Differentiation To Boost Anti-Tumor Immunity
Researchers at the University of California, Davis have developed a virally derived homolog to increase the inflammatory response desirable in cancer immunotherapy.
Transcription Active Complex Targeting Cancer Drug From Viral Protein Sequence
Researchers at the University of California, Davis have developed a viral peptide therapeutic that targets MYC-based cancerous tumors.
Recombinant Enhanced Antiviral Restrictors
Researchers at the University of California, Davis (“UC Davis”) have developed fusion proteins effective in inhibiting the replication of diverse groups of viruses that can be useful in controlling vector-borne virus transmission as well as reducing vector populations.
Mitochondria Targeting Photosensitizer for Photodynamic Therapy
Researchers at the University of California, Davis have developed a self-assembling, fibrous photosensitizer that targets mitochondria in tumor cells for destruction via photodynamic therapy with enhanced localization and potency.
Soluble Epoxide Hydrolase Inhibitors For The Treatment Of Arrhythmogenic Cardiomyopathy And Related Diseases
Researchers at the University of California, Davis have developed an effective drug therapy, utilizing Soluble Epoxide Hydrolase (sEH) inhibitors, to prevent sudden death and treat the progression of myocardial dysfunction in patients with Arrhythmogenic Cardiomyopathy (“ACM”).
A Discrete Color Approach for Stress Mitigation in Medical and Related Healthcare Applications as Applied to the Lighting Of Interiors and/or Medical Apparatus
The California Lighting Technology Center at UC Davis in collaboration with the Center for Mind and Brain have developed a novel lighting technology approach for stress recovery and stress mitigation.
Engineered Hcmv Protein-Derived Variants As Dr5 Agonist Immunotherapeutics For Solid And Pediatric Tumors
Researchers at the University of California, Davis have developed a new method for enhancing immunotherapy for solid cancer tumors by targeting multiple cancer cell elimination mechanisms simultaneously.
Use Of Terpenoids And Salicylates As Anesthetics, Analgesics, And Euthanasia Agents
Researchers at the University of California, Davis have developed agents made from terpenoids and salicylates that can be used as anesthetics in human and non-human animals, as well as environmentally friendly euthanasia agents in food-producing animals.
Polysaccharide A-Based Particulate Systems For Attenuation Of Autoimmunity, Allergy and Transplant Rejection
Researchers at the University of California, Davis have developed a customizable polysaccharide that can be added to nanoparticles to reduce their rejection by the human immune system.
Optimized Non-Addictive Biologics Targeting Sodium Channels Involved In Pain Signaling
Researchers at the University of California, Davis have developed high potency and selective peptide inhibitors that act as a non-addictive analgesic for relief of chronic and/or severe pain in humans.
Cannabigerol (CBG) In The Treatment Of Seizures And Epilepsy
Researchers at the University of California, Davis have developed a method of treating or mitigating seizure, treating epilepsy, as well as a method of reducing the frequency of seizures, using cannabigerol or dihydrocannabigerol and analogs thereof.
Portable Neural Network Enabled Biofluid Spectroscopy
Researchers at the University of California, Davis have developed a method of biofluid assessment capable of real-time monitoring as well as compatible with machine learning and neural network processing.
Psychoplastogens For Treating Hearing-Related Disorders
Researchers at the University of California, Davis, have developed a novel approach to treat hearing-related disorders with a new type of psychoplastogen that can increase the synapse density in the ear, correlating with hearing ability.